Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimer's Disease

E-ISSN： 1875-533x|18|36|5545-5553

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.36, 2011-12, pp. : 5545-5553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer's Disease: Emerging Trends in Small Molecule Therapies

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4299-4320

Bentham Science Publishers

Access to resources Recommend Favorite

A small-molecule lead compound for the treatment of Alzheimer’s disease

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 199-201

Informa Healthcare

Access to resources Recommend Favorite

Rutin as a Natural Therapy for Alzheimer’s Disease: Insights into its Mechanisms of Action

Current Medicinal Chemistry, Vol. 23, Iss. 9, 2016-03 ,pp. : 860-873

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica Rampa Angela Gobbi Silvia Bisi Alessandra

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite

Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4948-4957

Bentham Science Publishers

Access to resources Recommend Favorite